Skip to main content
Journal cover image

Tongue weakness and atrophy differentiates late-onset Pompe disease from other forms of acquired/hereditary myopathy.

Publication ,  Journal Article
Jones, HN; Hobson-Webb, LD; Kuchibhatla, M; Crisp, KD; Whyte-Rayson, A; Batten, MT; Zwelling, PJ; Kishnani, PS
Published in: Mol Genet Metab
July 2021

Late-onset Pompe disease (LOPD) is an inherited autosomal recessive progressive metabolic myopathy that presents in the first year of life to adulthood. Clinical presentation is heterogeneous, differential diagnosis is challenging, and diagnostic delay is common. One challenge to differential diagnosis is the overlap of clinical features with those encountered in other forms of acquired/hereditary myopathy. Tongue weakness and imaging abnormalities are increasingly recognized in LOPD. In order to explore the diagnostic potential of tongue involvement in LOPD, we assessed tongue structure and function in 70 subjects, including 10 with LOPD naive to treatment, 30 with other acquired/hereditary myopathy, and 30 controls with neuropathy. Tongue strength was assessed with both manual and quantitative muscle testing. Ultrasound (US) was used to assess tongue overall appearance, echointensity, and thickness. Differences in tongue strength, qualitative appearance, echointensity, and thickness between LOPD subjects and neuropathic controls were statistically significant. Greater tongue involvement was observed in LOPD subjects compared to those with other acquired/hereditary myopathies, based on statistically significant decreases in quantitative tongue strength and sonographic muscle thickness. These findings provide additional evidence for tongue involvement in LOPD characterized by weakness and sonographic abnormalities suggestive of fibrofatty replacement and atrophy. Findings of quantitative tongue weakness and/or atrophy may aid differentiation of LOPD from other acquired/hereditary myopathies. Additionally, our experiences in this study reveal US to be an effective, efficient imaging modality to allow quantitative assessment of the lingual musculature at the point of care.

Duke Scholars

Published In

Mol Genet Metab

DOI

EISSN

1096-7206

Publication Date

July 2021

Volume

133

Issue

3

Start / End Page

261 / 268

Location

United States

Related Subject Headings

  • Young Adult
  • Ultrasonography
  • Tongue
  • Muscular Diseases
  • Muscle Weakness
  • Middle Aged
  • Male
  • Late Onset Disorders
  • Humans
  • Glycogen Storage Disease Type II
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jones, H. N., Hobson-Webb, L. D., Kuchibhatla, M., Crisp, K. D., Whyte-Rayson, A., Batten, M. T., … Kishnani, P. S. (2021). Tongue weakness and atrophy differentiates late-onset Pompe disease from other forms of acquired/hereditary myopathy. Mol Genet Metab, 133(3), 261–268. https://doi.org/10.1016/j.ymgme.2021.05.005
Jones, Harrison N., Lisa D. Hobson-Webb, Maragatha Kuchibhatla, Kelly D. Crisp, Ashley Whyte-Rayson, Milisa T. Batten, Paul J. Zwelling, and Priya S. Kishnani. “Tongue weakness and atrophy differentiates late-onset Pompe disease from other forms of acquired/hereditary myopathy.Mol Genet Metab 133, no. 3 (July 2021): 261–68. https://doi.org/10.1016/j.ymgme.2021.05.005.
Jones HN, Hobson-Webb LD, Kuchibhatla M, Crisp KD, Whyte-Rayson A, Batten MT, et al. Tongue weakness and atrophy differentiates late-onset Pompe disease from other forms of acquired/hereditary myopathy. Mol Genet Metab. 2021 Jul;133(3):261–8.
Jones, Harrison N., et al. “Tongue weakness and atrophy differentiates late-onset Pompe disease from other forms of acquired/hereditary myopathy.Mol Genet Metab, vol. 133, no. 3, July 2021, pp. 261–68. Pubmed, doi:10.1016/j.ymgme.2021.05.005.
Jones HN, Hobson-Webb LD, Kuchibhatla M, Crisp KD, Whyte-Rayson A, Batten MT, Zwelling PJ, Kishnani PS. Tongue weakness and atrophy differentiates late-onset Pompe disease from other forms of acquired/hereditary myopathy. Mol Genet Metab. 2021 Jul;133(3):261–268.
Journal cover image

Published In

Mol Genet Metab

DOI

EISSN

1096-7206

Publication Date

July 2021

Volume

133

Issue

3

Start / End Page

261 / 268

Location

United States

Related Subject Headings

  • Young Adult
  • Ultrasonography
  • Tongue
  • Muscular Diseases
  • Muscle Weakness
  • Middle Aged
  • Male
  • Late Onset Disorders
  • Humans
  • Glycogen Storage Disease Type II